GU Cancers 2019 | Prostate cancer radiotherapy planning with Gallium-labelled PSMA-11 PET/CT imaging

Jeremie Calais

Jeremie Calais, MD, of the University of California, Los Angeles, CA, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA and discusses a Phase III randomised trial study (NCT03582774) investigating the efficacy of radiotherapy planning using Gallium-labelled PSMA-11 PET/CT imaging.

Share this video